VIMTA LABS
|
The Current P/E Ratio of VIMTA LABS is 50.23.
Share Price | ₹667.9 | Oct 23,2025 |
Market Cap | ₹2,971.9 Cr | |
Earnings-TTM | ₹59.2 Cr | TTM-Consolidated Results |
Price/Earnings | 50.23x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VIMTA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,971.9 Cr] as on Oct 23,2025
(/) Earnings [ ₹59.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 50.23x ]
Thus, for VIMTA LABS , the investors are currently willing to pay 50.23 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VIMTA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VIMTA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of VIMTA LABS
PE Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.22x.
- VIMTA LABS 's operated at median p/e ratio of 16.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 24.04x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2023 of 14.44x.
How does VIMTA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VIMTA LABS | 59.16 | 50.23 | 2,971.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.92 | 405,248.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 75.53 | 174,177.0 |
CIPLA LTD | 5,406.81 | 24.58 | 132,898.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.15 | 122,428.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.65 | 106,818.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.05 | 101,095.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.87 | 101,408.0 |
LUPIN LTD | 3,722.18 | 23.81 | 88,616.1 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.67 | 63,827.2 |
ABBOTT INDIA LTD | 1,452.29 | 44.04 | 63,959.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VIMTA LABS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.65x |
Max industry PE | 75.53x |
Median industry PE | 38.92x |
Average industry PE | 39.14x |
You may also like the below Video Courses